An integrated molecular risk score early in life for subsequent childhood asthma risk.

Böck, Andreas; Urner, Kathrin; Eckert, Jana Kristin; Salvermoser, Michael; Laubhahn, Kristina; Kunze, Sonja; Kumbrink, Jörg; Hoeppner, Marc P; Kalkbrenner, Kathrin; Kreimeier, Simone; Beyer, Kirsten; Hamelmann, Eckard; Kabesch, Michael; Depner, Martin; Hansen, Gesine; Riedler, Josef; Roponen, Marjut; Schmausser-Hechfellner, Elisabeth; Barnig, Cindy; Divaret-Chauveau, Amandine; ... (2024). An integrated molecular risk score early in life for subsequent childhood asthma risk. Clinical and experimental allergy, 54(5), pp. 314-328. Wiley 10.1111/cea.14475

Preview

Text Clin_Experimental_Allergy_-_2024_-_B_ck_-_An_integrated_molecular_risk_score_early_in_life_for_subsequent_childhood_asthma.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (2MB) | Preview

BACKGROUND

Numerous children present with early wheeze symptoms, yet solely a subgroup develops childhood asthma. Early identification of children at risk is key for clinical monitoring, timely patient-tailored treatment, and preventing chronic, severe sequelae. For early prediction of childhood asthma, we aimed to define an integrated risk score combining established risk factors with genome-wide molecular markers at birth, complemented by subsequent clinical symptoms/diagnoses (wheezing, atopic dermatitis, food allergy).

METHODS

Three longitudinal birth cohorts (PAULINA/PAULCHEN, n = 190 + 93 = 283, PASTURE, n = 1133) were used to predict childhood asthma (age 5-11) including epidemiological characteristics and molecular markers: genotype, DNA methylation and mRNA expression (RNASeq/NanoString). Apparent (ap) and optimism-corrected (oc) performance (AUC/R2) was assessed leveraging evidence from independent studies (Naïve-Bayes approach) combined with high-dimensional logistic regression models (LASSO).

RESULTS

Asthma prediction with epidemiological characteristics at birth (maternal asthma, sex, farm environment) yielded an ocAUC = 0.65. Inclusion of molecular markers as predictors resulted in an improvement in apparent prediction performance, however, for optimism-corrected performance only a moderate increase was observed (upto ocAUC = 0.68). The greatest discriminate power was reached by adding the first symptoms/diagnosis (up to ocAUC = 0.76; increase of 0.08, p = .002). Longitudinal analysis of selected mRNA expression in PASTURE (cord blood, 1, 4.5, 6 years) showed that expression at age six had the strongest association with asthma and correlation of genes getting larger over time (r = .59, p < .001, 4.5-6 years).

CONCLUSION

Applying epidemiological predictors alone showed moderate predictive abilities. Molecular markers from birth modestly improved prediction. Allergic symptoms/diagnoses enhanced the power of prediction, which is important for clinical practice and for the design of future studies with molecular markers.

Interest & Impact

Downloads

25 since deposited on 02 Apr 2024
25 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item